Discovery Life Sciences, a biospecimen/biomarker specialist, acquired ReachBio Research Labs, a company specializing in cell-based assays, predictive hematotoxicity, and drug screening services. The acquisition will allow Discovery to scale its consolidated drug discovery and preclinical development offerings to give customers access to a broader range of innovative and specialized cell biology services. “We are thrilled to welcome ReachBio to the Discovery family,” said Discovery...